Assignee
PHILOGEN SPA
IT34 patents
Top patents by PatentIndex Score
US7273924B1Sep 25, 2007
Antibodies to the ED-B domain of fibronectin, their construction and uses
PHILOGEN SPA24 citations91
US7968685B2Jun 28, 2011
Antibodies against Tenascin-C
PHILOGEN SPA24 citations88
US9181347B2Nov 10, 2015
Antigen associated with the neovasculature of tumour metastases
PHILOGEN SPA4 citations81
US10308696B2Jun 4, 2019
IL2 and TNF immunoconjugates
PHILOGEN SPA12 citations78
US7851599B2Dec 14, 2010
Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and gemcitabine
PHILOGEN SPA10 citations77
US9896503B2Feb 20, 2018
Antigen associated with the neovasculature of tumour metastases
PHILOGEN SPA2 citations70
US9446124B2Sep 20, 2016
Targeting of bone marrow neovasculature
PHILOGEN SPA3 citations70
US9198979B2Dec 1, 2015
Thiazolidine linker for the conjugation of drugs to antibodies
PHILOGEN SPA10 citations69
US9695232B2Jul 4, 2017
Anti-ED-A immunoconjugates for inflammatory bowel disease
PHILOGEN SPA2 citations66
US9096670B2Aug 4, 2015
Antibodies of the ED-B domain of fibronectin, their construction and uses
PHILOGEN SPA1 citations61
US11872288B2Jan 16, 2024
TNF-alpha immunoconjugate therapy for the treatment of brain tumors
PHILOGEN SPA2 citations59
US11103592B2Aug 31, 2021
IL2 and TNF mutant immunoconjugates
PHILOGEN SPA0 citations59
US11274133B2Mar 15, 2022
IL2 and TNF immunoconjugates
PHILOGEN SPA0 citations56
US11629199B2Apr 18, 2023
Antibodies to tumour antigens
PHILOGEN SPA0 citations55
US12023381B2Jul 2, 2024
Antibody compositions
PHILOGEN SPA0 citations54
US11351257B2Jun 7, 2022
Antibody compositions
PHILOGEN SPA1 citations54
US10647760B2May 12, 2020
Antibodies for treatment and diagnosis of inflammatory bowel disease
PHILOGEN SPA1 citations54
US10906963B2Feb 2, 2021
Non-glycosylated anti-tenascin antibody
PHILOGEN SPA0 citations51
US12173044B2Dec 24, 2024
EDB targeting IL-12 compositions
PHILOGEN SPA0 citations50
US12377161B2Aug 5, 2025
TNF-alpha immunoconjugate therapy for the treatment of brain tumors
PHILOGEN SPA0 citations49
US11390666B2Jul 19, 2022
Vascular endothelial growth factor/anti-fibronectin antibody fusion proteins
PHILOGEN SPA0 citations49
US10112992B2Oct 30, 2018
Antigens associated with endometriosis, psoriatic arthritis and psoriasis
PHILOGEN SPA0 citations49
US7109301B1Sep 19, 2006
Tenascin-C isoform as marker for neoplasias
PHILOGEN SPA1 citations49
US10385121B2Aug 20, 2019
Antigen associated with rheumatoid arthritis
PHILOGEN SPA0 citations48
US10239939B2Mar 26, 2019
Anti-ED-A immunoconjugates for inflammatory bowel disease
PHILOGEN SPA0 citations45
US9289470B2Mar 22, 2016
Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart
PHILOGEN SPA0 citations45
US10858411B2Dec 8, 2020
IL22 immunoconjugates
PHILOGEN SPA0 citations44
US10246502B2Apr 2, 2019
IL22 immunoconjugates
PHILOGEN SPA0 citations44
US10125190B2Nov 13, 2018
Anti-collagen antibodies for treatment and diagnosis
PHILOGEN SPA0 citations41
US10344079B2Jul 9, 2019
Methods of treating a neoplastic disease
PHILOGEN SPA0 citations39
US10202442B2Feb 12, 2019
Antigen associated with lung cancers and lymphomas
PHILOGEN SPA0 citations39
US10098976B2Oct 16, 2018
Antibodies for treatment and diagnosis
PHILOGEN SPA0 citations39
US10519246B2Dec 31, 2019
Anti-fibroblast activation protein (FAP) antibodies for treatment and diagnosis
PHILOGEN SPA0 citations36
US7723269B2May 25, 2010
Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use
PHILOGEN SPA0 citations20